院内心搏骤停期间血糖水平与成人患者结局的关联:一项10年回顾性队列研究
该单中心回顾性研究纳入2006至2015年580例院内心搏骤停(IHCA)且记录了骤停期间血糖的患者,34例(5.9%)达到神经功能完好存活,197例(34.0%)合并糖尿病,平均骤停期间血糖191.5 mg/dl,57例(9.8%)出现低血糖(血糖≤70 mg/dl),165例(28.4%)接受了葡萄糖注射。多因素逻辑回归显示骤停期间血糖≤150 mg/dl与出院时神经功能良好结局呈负相关(OR 0.28,95%CI 0.11-0.73,P=0.01);交互分析中非糖尿病×血糖≤168 mg/dl与神经功能良好结局呈负相关(OR 0.30,95%CI 0.11-0.80,P=0.02);血糖水平与葡萄糖给药之间无显著交互作用。作者结论认为骤停期间低血糖可能是危重症标志,对血糖≤150 mg/dl的IHCA患者给予葡萄糖未显示改善结局,提示需要开发葡萄糖给药以外的新疗法。
要点
- IHCA患者骤停期间血糖≤150 mg/dl与出院时神经功能良好结局呈负相关(OR 0.28,95%CI 0.11-0.73,P=0.01)。
- 非糖尿病患者骤停期间血糖≤168 mg/dl与神经功能良好结局呈负相关(OR 0.30,95%CI 0.11-0.80,P=0.02)。
- 580例中57例(9.8%)骤停期间血糖≤70 mg/dl,作者认为骤停期间低血糖可能是危重症标志。
- 血糖水平与葡萄糖给药之间无显著交互作用;对血糖≤150 mg/dl的IHCA患者给予葡萄糖未显示改善结局。
适用人群与场景
- 2006至2015年间单中心收治的院内心搏骤停(IHCA)成人患者,且骤停期间测量了血糖水平者。
诊断标准与关键阈值
- 骤停期间低血糖定义为血糖≤70 mg/dl。
- 骤停期间血糖≤150 mg/dl为与神经功能良好结局呈负相关的界值。
- 非糖尿病患者中骤停期间血糖≤168 mg/dl为与神经功能良好结局呈负相关的界值。
研究设计与关键结果
- 单中心回顾性队列研究,纳入580例IHCA患者,34例(5.9%)达到神经功能完好存活,197例(34.0%)合并糖尿病。
- 平均骤停期间血糖191.5 mg/dl,57例(9.8%)出现低血糖(血糖≤70 mg/dl),165例(28.4%)接受了葡萄糖注射。
- 骤停期间血糖≤150 mg/dl与出院时神经功能良好结局呈负相关(OR 0.28,95%CI 0.11-0.73,P=0.01)。
- 非糖尿病×血糖≤168 mg/dl与神经功能良好结局呈负相关(OR 0.30,95%CI 0.11-0.80,P=0.02)。
- 血糖水平与葡萄糖给药之间无显著交互作用。
证据类型、等级与局限
- 单中心回顾性队列研究,原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为骤停期间低血糖可能是危重症标志。
- 作者认为对骤停期间血糖≤150 mg/dl的IHCA患者给予葡萄糖未显示改善结局,提示需要开发葡萄糖给药以外的新疗法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: We attempted to examine the association between intra-arrest blood glucose (BG) level and outcomes of in-hospital cardiac arrest (IHCA). The interaction between diabetes mellitus (DM) and BG level as well as between dextrose administration and BG level were investigated.
METHODS: This single-centred retrospective study reviewed IHCA patients between 2006 and 2015. Patients with measured intra-arrest BG levels were included. Multivariable logistic regression analyses were conducted. Generalised additive models were used to identify appropriate cut-off points for continuous variables. Interactions between independent variables were assessed during the model-fitting process.
RESULTS: Among the 580 included patients, 34 (5.9%) achieved neurologically intact survival. There were 197 DM patients (34.0%). The mean intra-arrest BG level was 191.5 mg/dl, with 57 patients (9.8%) experiencing hypoglycaemia (BG level ≤ 70 mg/dl). A total of 165 patients (28.4%) received a dextrose injection. An intra-arrest BG level ≤ 150 mg/dl was inversely associated with favourable neurological outcomes at hospital discharge (odds ratio [OR]: 0.28, 95% confidence interval [CI]: 0.11-0.73; p-value = 0.01). In analyses of interactions, non-DM × BG level ≤ 168 mg/dl was inversely associated with favourable neurological outcomes (OR: 0.30, 95% CI: 0.11-0.80; p-value = 0.02). There were no significant interactions between BG level and dextrose administration.
CONCLUSION: IHCA patients with intra-arrest BG level ≤ 150 mg/dl had worse neurological recovery. Intra-arrest hypoglycaemia might be a marker of critical illness. Dextrose administration was not shown to improve outcomes of IHCA patients with intra-arrest BG level ≤ 150 mg/dl, indicating the need to develop new therapeutics other than dextrose administration for these patients.
参考来源
- Wang CH, Chang WT, Huang CH, et al. Associations between intra-arrest blood glucose level and outcomes of adult in-hospital cardiac arrest: A 10-year retrospective cohort study. Resuscitation. 2019. PMID: 31786236. doi:10.1016/j.resuscitation.2019.11.012
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。